Jump to Main Content

Press Releases

Hematologists from Developing Countries Participate in 2016 ASH Visitor Training Program

The American Society of Hematology (ASH) today announced the 20 hematologists and medical professionals from developing countries selected to participate in the 2016 ASH Visitor Training Program (VTP). Participants receive up to 12 weeks of specialized hematology training at host institutions in many different parts of the world. After the program, participants return home to implement their newly acquired skills and knowledge to address a specific need, helping to build hematology capacity and expertise at their respective institutions.

This year’s program includes participants from 15 countries who are training at top institutions in North America, Africa, Europe, and Australia. Their areas of study vary from bone marrow transplantation to hematologic malignancies and the management of sickle cell disease. VTP participants will carry out their training in the clinic or laboratory of an ASH member mentor. Additionally, participants will be assigned a counselor from the International Members Committee of ASH who will assist them with understanding the rigorous scientific community of ASH and evaluate the progress of both of the participant and the host mentor.

“ASH is proud of its continuous expansion of international training opportunities for hematologists around the globe, such as the Visitor Training Program,” said 2016 ASH President Charles S. Abrams, MD, of the University of Pennsylvania. “Program participants return home with new technical skills and ideas, and they share their knowledge with their colleagues, building strong hematology programs that lead to improved patient care in their home countries.”

The 2016 Visitor Training Participants are:

Participant &
Home Country
Training Topic Mentor &
Host Institution

Bewketu Abebe Alemu, MD
University of Gondar
North Gondar, Ethiopia

Training in interpretation of bone marrow aspirates and trephine biopsies Brigitte Cantinieaux, MD, PhD
CHU St. Pierre & Institut Bordet
Brussels, Belgium

Mohammad Ali, MBBS, FCPS
Dhaka Medical College Hospital
Dhaka, Bangladesh

Autologous stem cell transplantation Edmund K. Waller, MD, PhD, FACP
Emory Universit
Atlanta, GA
Popa Codruta, MD, PhD
Fundeni Clinical Institute
Bucharest, Romania
Flow cytometry for detection of MRD in patients with acute lymphoblastic leukemia (ALL) Michael Borowitz, MD, PhD
Johns Hopkins Universit
Baltimore, MD
Chinedu Ezekekwu, MBBS
University College Hospital
Ibadan, Nigeria
Therapeutic apheresis in the management of sickle cell disease Marilyn Telen, MD
Duke University
Durham, NC
Marcelo Luide Goncalves, MD, MSc
Hospital das Clínicas. Universidade Federal de Minas Gerais
Belo Horizonte, Brazil
Coagulation tests for thrombosis and hemostasis Flora Peyvandi, MD, PhD
Angelo Bianchi Bonomi Hemophilia & Thrombosis Center
Milan, Italy
Rodney Itaki, MBBS, BSc.Med
University of Papua New Guinea
Port Moresby, Papua New Guinea
Interpretation of peripheral smears, bone marrow aspirates, flow cytometry

Zeba Singh, MD
University of Maryland
Baltimore, MD

Anu Korula, MBBS, MD, DM
Christian Medical College
Vellore, India
Genetic diagnosis, allogeneic transplantation for immunodeficienies Parinda Mehta, MD
Cincinnati Children's Hospital
Cincinnati, OH
Misganaw Mengesha, MSc
Hawassa University Teaching Referral Hospital
Hawassa, Ethiopia
Flow cytometry for diagnosis & classification of leukemias Sung Choi, MD, MS
University of Michigan
Ann Arbor, MI
Dereen Mohammed, MD
Hiwa Cancer Hospital
Sulaymaniyah, Iraq
Training in the CD34 assay for stem cell monitoring; molecular biology for diagnosis of malignant hematology diseases Angelo Palmas, MD
Ospedale San Francesco
Nuoro, Italy
Zola Musimar, MD
Princess Marina Hospital
Gaborone, Botswana
Diagnosis and treatment of lymphoma subtypes Jeremy Abramson, MD, MMSc
Massachusetts General Hospital
Boston, MA
Adebola Olu-Taiwo, MBBS, MPH, FMCPath
Ekiti State University Teaching Hospital
Ado-Ekiti, Nigeria
Diagnosis & management of sickle cell disease Abdullah Kutlar, MD
GRU Medical College of Georgia
Augusta, GA
Anand Prakash, MD, FNB
St. John’s Medical College Hospital
Bengaluru, India
Diagnosis and treatment of pediatric hematolymphoid malignancy Carlos Alvarado, MD
Emory University Children's Center
Atlanta, GA
Don Rohan Pullaperuma, MBBS, MD
Hambantota General Hospital
Hambantota, Sri Lanka
Management of patients with hemaglobinopathies, especially sickle cell disease Enrico Novelli, MD, MS
University of Pittsburgh Medical Center
Pittsburgh, PA
Tatiana Saldarriaga, MD
Instituto Nacional de Salud del Niño San Borja
Lima, Peru
Bone marrow transplantation for malignant & non-malignant hematologic disorders Monica Thakar, MD
Children's Hospital of Wisconsin
Milwaukee, WI
Christine Sekaggya-Wiltshire, MBChB, MMed
Mulago National Referral Hospital
Kampala, Uganda
Interpretation of peripheral films, bone marrow aspirates & biopsies Julianne Qualtieri, MD
University of Cincinnati
Cincinnati, OH
Buddhika Somawardana, MBBS, MD
The National Cancer Institute
Maharagama, Sri Lanka
Clinical applications of flow cytometry for the management of hematological malignancies Michael Andreeff,
University of Texas MD Anderson Cancer Center
Houston, TX
Jennifer Thame, BSc, MBBS, DM
National Public Health
Kingston, Jamaica
Immunophenotyping using flow cytometry for diagnosis of leukemias & lymphomas; adult and pediatric Michael Linden, MD, PhD
University of Minnesota
Minneapolis, MN
Chi-kadibia Ukoma, MBBS
Federal Medical Centre
Keffi, Nigeria
Diagnosis of sickle cell disease using High Performance Liquid Chromatography for newborn screening program Julie Makani, MD, PhD, FRCP
Muhimbili University of Health & Allied Sciences
Dar es Salaam, Tanzania
Ernie Yap Sze Wei, MD
National University of Malaysia
Kuala Lumpur, Malaysia
Clinical and laboratory aspects of allogeneic stem cell transplantation Mary Ann Anderson, MBBS, FRACP, FRCPA
Royal Melbourne Hospital
Melbourne, Australia
Yasar Yousafzai, MBBS, PhD
Khyber Medical University
Peshawar, Pakistan
Diagnosis of hematological malignancies using flow cytometry Mhairi Copland, BSc, MBChB, FRCP, FRCPath, PhD
University of Glasgow
Glasgow, United Kingdom

The American Society of Hematology (www.hematology.org) is the world’s largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems by promoting research, clinical care, education, training, and advocacy in hematology. The official journal of ASH is Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online.

Sara Khalaf, American Society of Hematology
[email protected]; 202-552-4925